Gefitinib as first line therapy in Malaysian patients with EGFR mutation-positive non-small-cell lung cancer: A single-center retrospective study

por ABDULLAH, MATIN MELLOR, BHAT, AMIT, MOHAMED, AHMAD KAMAL, CHING, FOO YOKE, AHMED, NIDA, GANTOTTI, SANDEEP
Publicado 2016

Retrospective Analysis of Cancer Care Performance and Survival Outcome for Nasopharyngeal Carcinoma at a leading Cancer Treatment Centre in Malaysia 2008-2012

por Abdullah, Matin Mellor, Foo, Yoke Ching, Yap, Beng Khiong, Ling Lee, Catherine May, Hoo, L P, Lim, Teck Onn
Publicado 2019

Real-world experience of first-line afatinib in patients with EGFR-mutant advanced NSCLC: a multicenter observational study

por Ho, Gwo-Fuang, Chai, Chee-Shee, Alip, Adlinda, Wahid, Mohd Ibrahim A., Abdullah, Matin Mellor, Foo, Yoke-Ching, How, Soon-Hin, Zaatar, Adel, Lam, Kai-Seng, Leong, Kin-Wah, Low, John-Seng-Hooi, Yusof, Mastura Md, Lee, Erica Chai-Yong, Toh, Yok-Yong, Liam, Chong-Kin
Publicado 2019

Management of advanced prostate cancer in a middle‐income country: real‐world consideration of the Advanced Prostate Cancer Consensus Conference 2017

por Saad, Marniza, Alip, Adlinda, Lim, Jasmine, Abdullah, Matin Mellor, Chong, Flora Li Tze, Chua, Chong Beng, Ismail, Fuad, Khong, Rachael Kit‐Tsan, Lim, Chun Sen, Loh, Chit Sin, Malek, Rohan, Mohd Ghani, Khairul Asri, Md Noor, Ibtisam, Md Yusoff, Noor Ashani, Nasuha, Noor Azam, Razack, Azad, Soo Hoo, Hwoei Fen, Sundram, Murali, Tan, Hui Meng, Thiagarajan, Muthukkumaran, Teh, Guan Chou, Voon, Pei Jye, Ong, Teng Aik
Publicado 2019